Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 19, 2000
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorL S Zalman, M A Brothers, P S Dragovich, et al.AIDS (London, England)|April 15, 1999
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavirP Tebas, A K Patick, E M Kane, et al.Antimicrobial Agents and Chemotherapy|March 21, 2001
Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activitiesK E Zhang, E Wu, A K Patick, et al.Antimicrobial Agents and Chemotherapy|October 3, 1998
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavirA K Patick, M Duran, Y Cao, et al.Antimicrobial Agents and Chemotherapy|January 28, 2005
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitorS L Binford, F Maldonado, M A Brothers, et al.Antimicrobial Agents and Chemotherapy|February 1, 1995
Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and proteaseC M Bechtold, A K Patick, M Alam, et al.Antimicrobial Agents and Chemotherapy|February 1, 1996
Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus proteaseA K Patick, H Mo, M Markowitz, et al.Bioorganic & Medicinal Chemistry|June 3, 1999
Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amidesP S Dragovich, R Zhou, D J Skalitzky, et al.Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitorP F Lin, H Samanta, C M Bechtold, et al.Antiviral Research|October 1, 1993
Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsM Alam, C M Bechtold, A K Patick, et al.Pageof 5